Search - tctmd.com

Displaying 401 - 420 of 901

Sort: Relevancy | Date

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

News Daily News

CMR Picks Up Pericardial Inflammation in Student Athletes With COVID-19

Michael O'Riordan

November 06, 2020

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Daily News

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Michael O'Riordan

October 30, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Daily News

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Michael O'Riordan

October 21, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Michael O'Riordan

October 17, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Daily News

ESC and EACTS Announce Review of Left Main Revascularization Guidelines

Michael O'Riordan

October 06, 2020

News Daily News

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

Michael O'Riordan

September 28, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Michael O'Riordan

September 22, 2020

News Daily News

Hostility After ACS Linked to All-Cause Mortality

Michael O'Riordan

September 21, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

Advertisement

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

CMR Picks Up Pericardial Inflammation in Student Athletes With COVID-19

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

ESC and EACTS Announce Review of Left Main Revascularization Guidelines

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Hostility After ACS Linked to All-Cause Mortality

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

PCI Volumes Rise in US and Japan, but for Different Reasons

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content